tiprankstipranks

Intra-Cellular downgraded to Neutral from Outperform at Mizuho

Intra-Cellular downgraded to Neutral from Outperform at Mizuho

Mizuho analyst Graig Suvannavejh downgraded Intra-Cellular (ITCI) to Neutral from Outperform with a price target of $132, down from $140, after Johnson & Johnson (JNJ) agreed to acquire all of the company’s outstanding shares for $132 in cash. The firm sees no reason for the pending takeover deal to get blocked, especially in light of recent precedent transactions. In addition, another bidder is unlikely to emerge at this point, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue